]>
IRCT20200913048701N1 IRCT 2020-09-22 Iran University of Medical Sciences Evaluation of effects of eucalyptus tablets on the process of covid 19 disease Evaluation of therapeutic effects of oral eucalyptus tablets on the treatment process of patients with Covid 19 infection. 2020-09-22 anticipated 50 Complete https://irct.ir/trial/50912 interventional Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, after obtaining informed consent from eligible individuals, individuals will be randomly divided into two groups using the number table method. In this way, patients who are candidates for inclusion in the study, after reviewing the inclusion and exclusion criteria and obtaining informed consent, a number will be given to people using the software, and based on this random number, people will be given one of the two The study group will belong, Blinding description: This study is three-way blind, so that the subject and the clinician conducting the research who monitors the patients and the statistical analyzer are unaware of the status of the two groups assigned to the study. Labels on medicine packages will be removed. The subject is not aware of the status of assignment to groups. The researcher who makes clinical and diagnostic measurements will not be aware of the status of individuals, nor will the statistical consultant be unaware of the allocation of individuals to study groups. Only one observer will be aware of the allocation of groups. 3 COVID-19 disease. Intervention 1: Intervention group: Patients undergoing intervention with Eucalyptus soft oral capsule from Barij Essential Oil Company containing Eucalyptus essential oil (Eucalyptus globulus) Active ingredients 8 (Cineol (Eucalyptol), Alpha-Pinene, Lemonene) in accordance with the approved drug catalog of the Food and Drug Administration 8 hours for 5 days. Intervention 2: Control group: Patients are not intervened. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is There is no more information.
public Hossein Shirazi
No. 49, Taleghani Ave., Miri Blvd., Varamin Town
Varamin Iran (Islamic Republic of) 3371673634 +98 21 3625 6451 shirazi.h@iums.ac.ir Iran University of Medical Sciences scientific Hossein Shirazi
No. 49, Taleghani Ave., Miri Blvd., Varamin Town
Varamin Iran (Islamic Republic of) 3371673634 +98 21 3625 6451 shirazi.h@iums.ac.ir Iran University of Medical Sciences Iran (Islamic Republic of) Patients between 40 and 60 years of age with new coronavirus infection 2019 who have been admitted to Firoozabadi Hospital. 40 years 60 years Both Age over 60 years Age under 40 years No hospitalization No infection with coronavirus 2019 U07.1 COVID-19 Treatment - Drugs Treatment - Drugs Intervention group: Patients undergoing intervention with Eucalyptus soft oral capsule from Barij Essential Oil Company containing Eucalyptus essential oil (Eucalyptus globulus) Active ingredients 8 (Cineol (Eucalyptol), Alpha-Pinene, Lemonene) in accordance with the approved drug catalog of the Food and Drug Administration 8 hours for 5 days Control group: Patients are not intervened. Blood oxygen level (SPO2%). Timepoint: Before the intervention, and 3, 5 and 7 days after the intervention. Method of measurement: Pulse oximeter device. Inflammatory index CRP. Timepoint: Before the intervention, and 3, 5 and 7 days after the intervention. Method of measurement: blood test. Cough. Timepoint: Before the intervention, and 3, 5 and 7 days after the intervention. Method of measurement: Qualitative (mild-moderate-severe). Blood lymphocyte count. Timepoint: Before the intervention, and 3, 5 and 7 days after the intervention. Method of measurement: blood test. White blood cell count. Timepoint: Before the intervention, and 3, 5 and 7 days after the intervention. Method of measurement: blood test. The rate of disease progression. Timepoint: Before the intervention, and 3, 5 and 7 days after the intervention. Method of measurement: Researcher checklist. Duration of hospitalization. Timepoint: Before the intervention and 7 days after the intervention. Method of measurement: Researcher checklist. Iran University of Medical Sciences Approved 2020-09-13 Ethics committee of Iran University of Medical Sciences Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran, Iran Tehran Tehran Iran (Islamic Republic of)